American Journal of Cardiology
Volume 106, Issue 3 , Pages 329-336 , 1 August 2010

Incidence and Risk Factors of Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation (3-Year Follow-Up of the j-Cypher Registry)

  • Yoshihisa Nakagawa, MD

      Affiliations

    • Division of Cardiology, Tenri Hospital, Tenri, Japan
    • Corresponding Author InformationCorresponding author: Tel: 81-743-63-5611; fax: 81-743-63-1530
    • ,
  • Takeshi Kimura, MD

      Affiliations

    • Department of Cardiovascular of Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    • ,
  • Takeshi Morimoto, MD

      Affiliations

    • Center for Medical Education and Clinical Epidemiology Unit, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    • ,
  • Masanori Nomura, MD

      Affiliations

    • Fujita Health University, Banbuntane Houtokukai Hospital, Aichi, Japan
    • ,
  • Keijiro Saku, MD

      Affiliations

    • Fukuoka University Hospital, Fukuoka, Japan
    • ,
  • Seiichi Haruta, MD

      Affiliations

    • Fukuyama Cardiovascular Hospital, Fukuyama, Japan
    • ,
  • Toshiya Muramatsu, MD

      Affiliations

    • Kawasaki Social Insurance Hospital, Kawasaki, Japan
    • ,
  • Masakiyo Nobuyoshi, MD

      Affiliations

    • Kokura Memorial Hospital, Kokura, Japan
    • ,
  • Kazushige Kadota, MD

      Affiliations

    • Kurashiki Central Hospital, Kurashiki, Japan
    • ,
  • Hiroshi Fujita, MD

      Affiliations

    • Kyoto Second Red Cross Hospital, Kyoto, Japan
    • ,
  • Ryozo Tatami, MD

      Affiliations

    • Maizuru Kyosai Hospital, Maizuru, Japan
    • ,
  • Nobuo Shiode, MD

      Affiliations

    • Matsue Red Cross Hospital, Matsue, Japan
    • ,
  • Hideo Nishikawa, MD

      Affiliations

    • Mie Heart Center, Mie, Japan
    • ,
  • Yoshisato Shibata, MD

      Affiliations

    • Miyazaki Ishikai Hospital, Miyazaki, Japan
    • ,
  • Shunichi Miyazaki, MD

      Affiliations

    • National Cardiovascular Center, Suita, Japan
    • ,
  • Yoshiharu Murata, MD

      Affiliations

    • Noto General Hospital, Nanao, Japan
    • ,
  • Takashi Honda, MD

      Affiliations

    • Saiseikai Kumamoto Hospital, Kumamoto, Japan
    • ,
  • Tomohiro Kawasaki, MD

      Affiliations

    • Shin-Koga Hospital, Kurume, Japan
    • ,
  • Osamu Doi, MD

      Affiliations

    • Shizuoka General Hospital, Shizuoka, Japan
    • ,
  • Yoshikazu Hiasa, MD

      Affiliations

    • Tokushima Red Cross Hospital, Tokushima, Japan
    • ,
  • Yasuhiko Hayashi, MD

      Affiliations

    • Tsuchiya General Hospital, Hiroshima, Japan
    • ,
  • Masunori Matsuzaki, MD

      Affiliations

    • Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University, Graduate School of Medicine, Ube, Japan
    • ,
  • Kazuaki Mitsudo, MD

      Affiliations

    • Kokura Memorial Hospital, Kokura, Japan
    • ,
  • j-Cypher Registry Investigators

Received 21 January 2010 ,Revised 17 March 2010 ,Accepted 17 March 2010.

References 

  1. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999;100:1872–1878
  2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
  3. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221–231
  4. Claessen BE, Beijk MA, Legrand V, Ruzyllo W, Manari A, Varenne O, et al. Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II Trial. Circ Cardiovasc Interv. 2009;2:339–347
  5. Wessely R, Kastrati A, Schömig A. Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent. Ann Intern Med. 2005;143:392–394
  6. Cosgrave J, Corbett SJ, Melzi G, Babic R, Biondi-Zoccai GG, Airoldi F, et al. Late restenosis following sirolimus-eluting stent implantation. Am J Cardiol. 2007;100:41–44
  7. Hong MK, Mintz GS, Lee CW, Park DW, Lee SW, Kim YH, et al. Late target lesion revascularization after implantation of sirolimus-eluting stent. Catheter Cardiovasc Interv. 2008;71:299–303
  8. Rodriguez AE, Maree AO, Mieres J, Berrocal D, Grinfeld L, Fernandez-Pereira C, et al. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry. Eur Heart J. 2007;28:2118–2125
  9. Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009;119:987–995
  10. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2007;11:41–50
  11. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344–2351
  12. Kimura T, Yokoi H, Nakagawa Y, Tamura T, Kaburagi S, Sawada Y, et al. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med. 1996;334:561–566
  13. Kimura T, Abe K, Shizuta S, Odashiro K, Yoshida Y, Sakai K, et al. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation. 2002;105:2986–2991
  14. Kastrati A, Schömig A, Elezi S, Schühlen H, Dirschinger J, Hadamitzky M, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol. 1997;30:1428–1436
  15. Bauters C, Hubert E, Prat A, Bougrimi K, Van Belle E, McFadden EP, et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol. 1998;31:1291–1298
  16. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?. Circulation. 2004;109:701–705
  17. Higo T, Ueda Y, Oyabu J, Okada K, Nishio M, Hirata A, et al. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study. JACC Cardiovasc Imaging. 2009;2:616–624
  18. Aoki J, Nakazawa G, Tanabe K, Hoye A, Yamamoto H, Nakayama T, et al. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv. 2007;69:380–386
  19. Fajadet J, Morice MC, Bode C, Barragan P, Serruys PW, Wijns W, et al. Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial. Circulation. 2005;111:1040–1044
  20. Weisz G, Leon MB, Holmes DR, Kereiakes DJ, Popma JJ, Teirstein PS, et al. Five-year follow-up after sirolimus-eluting stent implantation: results of the SIRIUS trial. J Am Coll Cardiol. 2009;53:1488–1497

 This study was supported by Cordis Cardiology Japan, a Johnson and Johnson Company, Tokyo, Japan.

PII: S0002-9149(10)00780-0

doi: 10.1016/j.amjcard.2010.03.031

American Journal of Cardiology
Volume 106, Issue 3 , Pages 329-336 , 1 August 2010

Article Tools

* Image Usage & Resolution